EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis

Jeremy R Bjelajac, Adrià Cañellas-Socias, Preeti Nehra, Kevin Reynolds, Meena Malipatlolla, Naiara Martinez Velez, Diane C Manjarrez, Katie Ho, Peng Xu, Jennifer L Hamad, Sean A Yamada-Hunter, Louai Labanieh und 2 weitere

Cell · 2026-06 · 189 (13) · 3883-3902.e23

DOI: 10.1016/j.cell.2026.04.037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2026-06. Verfasst von Jeremy R Bjelajac und 13 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell and Regenerative Medicine Graduate Program, Stanford University School of Medicine, Stanford, CA, USA; Center for Cancer Cell Therapy, Stan…. Hauptthemen laut MEDLINE: ADAM17 Protein, Receptors, Chimeric Antigen, Receptors, Antigen, T-Cell. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, European Molecular Biology Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We sought to endow T cell autonomous regulation of cell surface protein expression by exploiting the conditional proteolytic activity of ADAM17 following T cell activation. Screening of canonical ADAM17 substrates yielded a minimal 15-aa CD62L-derived motif that confers rapid and reversible cleavage of a receptor following T cell activation-termed activation-induced release (AIR). Embedding AIR into tonic-signaling CARs reduced basal CAR expression proportional to the degree of tonic signaling induced, curtailing exhaustion and improving antitumor potency. In non-tonic signaling CARs, AIR decreased activation-induced cell death and enhanced T cell expansion after stimulation. AIR's modularity supports higher-order logic-gating; AIR-regulated peptide masks enable antigen-dependent unmasking of an EGFR-targeting CAR. Finally, CRISPR knockin of AIR into endogenous FAS or TGFBR2 endowed them with activation-induced shedding, which enhanced tumor clearance while preserving signaling in non-activating conditions. AIR is a compact switch that provides fast, autonomous regulation of surface proteins for next-generation cell therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAM17 ProteinReceptors, Chimeric AntigenReceptors, Antigen, T-CellHumansProteolysisSignal TransductionAnimalsT-LymphocytesLymphocyte ActivationMice

Stichwörter der Autor:innen

ADAM17CART cellsbioengineeringcancerimmunotherapyproteasesynthetic biology

Substanzen

ADAM17 ProteinADAM17 protein, humanReceptors, Chimeric AntigenReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • Stem Cell and Regenerative Medicine Graduate Program, Stanford University School of Medicine, Stanford, CA, USA; Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanfor…
  • Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA; Weill West Coast Cancer Hub, Stanford, CA, USA.
  • Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Chemistry, Stanford University, Stanford, CA, USA; Department of Biology, Stanford University, Stanford, CA, USA.
  • Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA; Parker Institute for Cancer Immunotherapy, Stanford University School of Medicine, Stanford, CA, USA.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • European Molecular Biology Organization
  • Saint Baldricks Foundation
  • National Institutes of Health
  • CRIS Cancer Foundation
  • Ramon Areces Foundation
  • National Science Foundation

Zitieren

APA

Bjelajac, J. R., Cañellas-Socias, A., Nehra, P., Reynolds, K., Malipatlolla, M., Martinez Velez, N., Manjarrez, D. C., Ho, K., Xu, P., Hamad, J. L., Yamada-Hunter, S. A., Labanieh, L., Sotillo, E., & Mackall, C. L. (2026). Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis. Cell, 189(13), 3883-3902.e23. https://doi.org/10.1016/j.cell.2026.04.037

Vancouver

Bjelajac JR, Cañellas-Socias A, Nehra P, Reynolds K, Malipatlolla M, Martinez Velez N, et al. Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis. Cell. 2026;189(13):3883-3902.e23. doi:10.1016/j.cell.2026.04.037

BibTeX
@article{Bjelajac2026,
  author = {Bjelajac, Jeremy R and Cañellas-Socias, Adrià and Nehra, Preeti and Reynolds, Kevin and Malipatlolla, Meena and Martinez Velez, Naiara and Manjarrez, Diane C and Ho, Katie and Xu, Peng and Hamad, Jennifer L and Yamada-Hunter, Sean A and Labanieh, Louai and Sotillo, Elena and Mackall, Crystal L},
  title = {Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis},
  journal = {Cell},
  year = {2026},
  volume = {189},
  number = {13},
  pages = {3883--3902.e23},
  doi = {10.1016/j.cell.2026.04.037}
}
Kostenlos starten →